TL;DR
OpenAI eyes $40B raise; Chime surges 59% in IPO; Yale to sell $6B in PE/VC.
Highlights
- OpenAI in talks for a $40B round led by SoftBank, with Saudi PIF, Reliance, and UAE’s MGX; targets another $17B raise in 20271.
- AI and robotics startups attract major funding: Glean valued at $7.2B, Cyera raises $540M (valuation up to $6B), Multiverse Computing secures €189M, and Coco Robotics raises $80M for 10,000 delivery vehicles by 20262.
- Samsung and Nvidia (NVDA ) invest $35M in Skild AI’s $4.5B Series B, led by SoftBank, focusing on consumer robotics3.
- Chime shares surge 59% in Nasdaq debut after $864M IPO, valuing the fintech at $11.6B4.
- BioNTech to acquire CureVac for $1.25B in stock, consolidating mRNA cancer therapy pipelines5.
- Yale University seeks to sell up to $6B in private equity and VC holdings amid sector underperformance and regulatory scrutiny6.
- Databricks launches a free edition, $100M talent fund, and deepens cloud partnerships with Microsoft and Google Cloud7.
- Nominal raises $75M Series B led by Sequoia (closed in 10 days); Alfred Lin joins board8.
- Honda (HMC ) to invest in Rapidus for advanced auto chips; Denso shifts to Rohm; Xpeng (XPEV ) debuts G7 SUV with in-house AI chip, targeting Volkswagen partnership911.
- Micron to invest $200B in US chip fabs and R&D, aiming for 40% of global DRAM output in the US by 203010.
- Tesla (TSLA ) sues ex-engineer and Proception for alleged Optimus robot trade-secret theft12.
- China allows Hong Kong and Macau GBA firms to list on Shenzhen with eased requirements, expanding cross-border capital market access15.
Commentary
AI and robotics continue to dominate late-stage venture activity, with OpenAI’s $40B fundraising talks and a pipeline for further capital in 2027 setting a new bar for scale1. Major sovereign and strategic investors are deepening their exposure, and SoftBank is again central to the largest rounds, also leading Skild AI’s $4.5B Series B3. The surge in funding for Glean, Cyera, and Coco Robotics reflects sustained investor appetite for AI-driven enterprise and automation solutions, as well as robotics platforms moving toward commercialization2.
Chime’s strong Nasdaq debut, with shares up 59% post-IPO, signals renewed public market demand for high-growth fintechs and could encourage more tech IPOs in the near term4. However, Yale’s intent to offload $6B in private equity and venture holdings highlights institutional caution regarding private market valuations, liquidity, and regulatory scrutiny—raising questions about future secondary market dynamics and the sustainability of current late-stage valuations6.
Strategic M&A and hardware investments remain active: BioNTech’s CureVac acquisition consolidates mRNA assets for oncology5, while Micron’s $200B US chip initiative and Honda’s investment in Rapidus underscore the strategic value of domestic semiconductor supply and proprietary hardware109. Xpeng’s (XPEV ) launch of the G7 SUV with an in-house AI chip, and its partnership with Volkswagen, further illustrate the trend toward vertical integration in automotive tech11.
For early-stage investors, Databricks’ expanded startup program and Nominal’s rapid $75M Series B (with Sequoia’s Alfred Lin joining the board) highlight that technical depth and market relevance in AI, data, and defense continue to drive fast funding cycles78. China’s move to allow GBA firms dual listings in Shenzhen could provide new liquidity and exit options for startups with cross-border ambitions15.
VCs should monitor further mega-rounds in AI/robotics, the pace of tech IPOs, secondary market activity from large LPs, and the evolving regulatory environment impacting capital flows and valuations.